154 related articles for article (PubMed ID: 21228768)
21. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.
Zhang L; Rajan V; Lin E; Hu Z; Han HQ; Zhou X; Song Y; Min H; Wang X; Du J; Mitch WE
FASEB J; 2011 May; 25(5):1653-63. PubMed ID: 21282204
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease.
Verzola D; Bonanni A; Sofia A; Montecucco F; D'Amato E; Cademartori V; Parodi EL; Viazzi F; Venturelli C; Brunori G; Garibotto G
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):131-144. PubMed ID: 27897392
[TBL] [Abstract][Full Text] [Related]
23. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.
Sharma M; Kambadur R; Matthews KG; Somers WG; Devlin GP; Conaglen JV; Fowke PJ; Bass JJ
J Cell Physiol; 1999 Jul; 180(1):1-9. PubMed ID: 10362012
[TBL] [Abstract][Full Text] [Related]
24. Skeletal muscle of gastric cancer patients expresses genes involved in muscle regeneration.
Pessina P; Conti V; Pacelli F; Rosa F; Doglietto GB; Brunelli S; Bossola M
Oncol Rep; 2010 Sep; 24(3):741-5. PubMed ID: 20664982
[TBL] [Abstract][Full Text] [Related]
25. Norepinephrine induces apoptosis in neonatal rat endothelial cells via a ROS-dependent JNK activation pathway.
Fu YC; Yin SC; Chi CS; Hwang B; Hsu SL
Apoptosis; 2006 Nov; 11(11):2053-63. PubMed ID: 17041759
[TBL] [Abstract][Full Text] [Related]
26. Signaling pathways weigh in on decisions to make or break skeletal muscle.
Guttridge DC
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):443-50. PubMed ID: 15192448
[TBL] [Abstract][Full Text] [Related]
27. Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt.
Morissette MR; Cook SA; Buranasombati C; Rosenberg MA; Rosenzweig A
Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1124-32. PubMed ID: 19759331
[TBL] [Abstract][Full Text] [Related]
28. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure.
Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ
J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586
[TBL] [Abstract][Full Text] [Related]
29. IGF-I, IGF-II, and IGF-receptor-1 transcript and IGF-II protein expression in myostatin knockout mice tissues.
Kocamis H; Gahr SA; Batelli L; Hubbs AF; Killefer J
Muscle Nerve; 2002 Jul; 26(1):55-63. PubMed ID: 12115949
[TBL] [Abstract][Full Text] [Related]
30. Peptidoglycan induces interleukin-6 expression through the TLR2 receptor, JNK, c-Jun, and AP-1 pathways in microglia.
Lin HY; Tang CH; Chen JH; Chuang JY; Huang SM; Tan TW; Lai CH; Lu DY
J Cell Physiol; 2011 Jun; 226(6):1573-82. PubMed ID: 20945380
[TBL] [Abstract][Full Text] [Related]
31. Undernutrition regulates the expression of a novel splice variant of myostatin and insulin-like growth factor 1 in ovine skeletal muscle.
Jeanplong F; Osepchook CC; Falconer SJ; Smith HK; Bass JJ; McMahon CD; Oldham JM
Domest Anim Endocrinol; 2015 Jul; 52():17-24. PubMed ID: 25700268
[TBL] [Abstract][Full Text] [Related]
32. Exercise capacity in chronic heart failure patients is related to active gene transcription in skeletal muscle and not apoptosis.
Conraads VM; Hoymans VY; Vermeulen T; Beckers P; Possemiers N; Maeseneer MD; Vrints C; Martinet W
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):325-32. PubMed ID: 19318954
[TBL] [Abstract][Full Text] [Related]
33. Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease.
Ju CR; Chen RC
Respir Med; 2012 Jan; 106(1):102-8. PubMed ID: 21840694
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin.
Chen Y; Cao L; Ye J; Zhu D
Biochem Biophys Res Commun; 2009 Oct; 388(1):112-6. PubMed ID: 19646957
[TBL] [Abstract][Full Text] [Related]
35. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
[TBL] [Abstract][Full Text] [Related]
36. Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney Disease.
Wang DT; Yang YJ; Huang RH; Zhang ZH; Lin X
Oxid Med Cell Longev; 2015; 2015():684965. PubMed ID: 26448817
[TBL] [Abstract][Full Text] [Related]
37. Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection.
Shao C; Liu M; Wu X; Ding F
Microsurgery; 2007; 27(5):487-93. PubMed ID: 17596894
[TBL] [Abstract][Full Text] [Related]
38. Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells.
Romero L; Andrews K; Ng L; O'Rourke K; Maslen A; Kirby G
Biochem J; 2006 Nov; 400(1):135-41. PubMed ID: 16836488
[TBL] [Abstract][Full Text] [Related]
39. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure.
Moorjani N; Westaby S; Narula J; Catarino PA; Brittin R; Kemp TJ; Narula N; Sugden PH
Am J Cardiol; 2009 May; 103(9):1261-8. PubMed ID: 19406269
[TBL] [Abstract][Full Text] [Related]
40. Increased Smad signaling and reduced MRF expression in skeletal muscle from obese subjects.
Watts R; McAinch AJ; Dixon JB; O'Brien PE; Cameron-Smith D
Obesity (Silver Spring); 2013 Mar; 21(3):525-8. PubMed ID: 23404842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
